Stratasys Q2 EPS Beats, But Cash Flow Guidance Turns Negative for 2026
SSYS sits 22% above its 52-week low of $7.34.
Summary
Stratasys beat Q2 EPS estimates with record consumables sales and strong A&D growth, but cut its full-year operating cash flow guidance to negative due to atypical H1 cash usage.
Key Events · Earnings and Guidance · SSYS
-
Q2 EPS Beat
Non-GAAP EPS of $0.03 beat consensus of $0.008, with revenue of $137.6M, down 0.4% YoY but up 3.7% sequentially.
-
Cash Flow Guidance Cut
Full-year 2026 operating cash flow revised from positive to negative, though H2 2026 is expected to be positive. Q2 cash used in operations was $18.7M, driven by legal expenses and non-routine items.
-
Record Consumables Revenue
Consumables revenue reached a record $66.3M, up 3.3% YoY, underscoring the shift toward manufacturing.
-
Aerospace & Defense Growth
A&D revenue grew 17% YoY, the largest vertical, driven by USAF adoption and defense demand.
Analysis · SSYS · Technology
Stratasys reported Q2 non-GAAP EPS of $0.03, beating consensus, with record consumables revenue and 17% growth in Aerospace and Defense. However, the company revised its full-year 2026 operating cash flow outlook from positive to negative due to higher-than-expected cash usage in H1, driven by legal expenses and other non-routine items. The balance sheet remains strong with $212.5M in cash and no debt, and the Markforged acquisition is on track to close by end of 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SSYS was trading at $8.99 on NASDAQ in the Technology sector, with a market capitalization of approximately $761.8M. The 52-week trading range was $7.34 to $12.81. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.